Ira Studin, PhD

Ira Studin, PhD, MPH, is president of Stellar Managed Care Consulting, a pharma busines strategies firm in Cherry Hill, New Jersey. He has written Strategic Healthcare Management and numerous articles in healthcare business journals. He can be reached at istudin@stellarmc.com

Articles

Obesity Drugs in the Payer Market: What to Expect

Payers won’t let these products break the bank.

‘Bolus’ Markets: Unique Business Opportunities with Promise and Risk

Conditions require a disciplined approach to drug pricing.

The Payer Value Deficit in Orphan Drugs

Shift focus in orphan and ultra-orphan messaging to clinical benefit.

Payer Key Business Factors for Orphan Product Launches

Supporting health plan clinical preparation and financial modeling.

Exploring Fixed and Variable Coverage Principles

Different paths to formulary decision-making.

If Non-Formulary Hospital, Price May Not Be the Rx

Reversing non-formulary status will usually require new data.